Join
Live feed
·
INSIDERFilingvia Quantisnow
Global Blood Therapeutics Inc. logo

SEC Form 4: Habibizad Nazila returned 39,680 shares to the company, closing all direct ownership in the company (for withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.
GBT· Global Blood Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GBT (Global Blood Therapeutics Inc.) and more on Quantisnow.